3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Neoplasms
9
Breast Neoplasms
8
Colonic Neoplasms
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Respiratory Aspiration
3
Brain Neoplasms
3
Supratentorial Neoplasms
2
Rectal Neoplasms
2
Pituitary Neoplasms
2
Patient Satisfaction
2
Emergence Delirium
2
Agnosia
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Ulcer
1
Stomach Neoplasms
1
Seizures
1
Respiration Disorders
1
Recovery
1
Rare Diseases
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Postoperative Cognitive Complications
1
Polyps
1
Pain, Postoperative
1
Pain
1
Overweight
1
Obesity
1
Neurofibromatoses
1
Interventions
Metformin
14
Exercise
14
Resistance Training
5
Nutrition Assessment
5
Methods
5
Exenatide
5
Diet
5
Diet Therapy
4
Surveys and Questionnaires
3
Sugars
3
Early Intervention, Educational
3
Counseling
3
Caloric Restriction
3
exemestane
2
Yoga
2
Vitamin D
2
Nutritional Status
2
Naltrexone
2
Mindfulness-Based Stress Reduction
2
Liraglutide
2
Educational Status
2
Docosahexaenoic Acids
2
Diet, Mediterranean
2
Cognitive Behavioral Therapy
2
Bupropion
2
Blood Specimen Collection
2
sibutramine
1
rosiglitazone-metformin combination
1
penclomedine
1
licogliflozin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Obesity
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled